At Excel Medicine, were noticing the same trend: patients are feeling their way toward individualized dosing long before the data exists to support it
Safety Considerations and NHS Guidance on Berberine Whilst berberine appears generally well-tolerated in short-term studies (often using doses of 500 mg two to three times daily), several important safety considerations warrant attention
10.1007/s001250051445 29
Paired with Stelo by Dexcom and the Signos AI platform, patients see the metabolic consequences of their choices in real time: For patients with PCOS, perimenopause, prediabetes, insulin resistance, or post-GLP-1 weight maintenance needs, Signos turns invisible metabolic dysfunction into legible, actionable data
Think of it this way: semaglutide pulls one lever to help you lose weight, tirzepatide pulls two, and retatrutide pulls three